PNPLA8 and triple-negative breast carcinoma: Second, we have discovered that PNPLA8 is a key master regulator of phospholipid reprogramming and eicosanoid signaling induced proliferation and migration in triple-negative breast cancer, which could be translated to the clinic as a novel diagnostic immunohistochemistry marker.